NCT05000073

Brief Summary

The report of the Epidemiological and Information Network in Nephrology counted 44,978 hemodialysis patients in France in 2017, with more than 93% of them attending 3 sessions per week. This multi-weekly recourse to the healthcare system in the context of substitution treatment constantly reminds patients of their disease and has a strong impact on their quality of life. The 2011 REIN quality of life report showed that the quality of life of patients with renal failure, particularly dialysis patients, is impaired, particularly in its physical and mental components. A recent comparative study (van Sandwijk et al., 2019) comparing hemodialysis patients with hematological cancer patients under chemotherapy supports these data. The June 2013 report of the "Etats généraux du rein", an initiative of patient associations, called for the improvement of quality of life to be made a priority and for the possibility of using supportive care and complementary non-drug techniques to be proposed. Socio-aesthetic care, defined "as the practice of aesthetic care for people who are suffering or vulnerable", has found its place in hospitals as a complementary discipline to medical care, particularly in oncology. We believe that in order to improve the overall quality of life of hemodialysis patients, the quality of the experience of each session must be improved. In this perspective, the repetition of socio-aesthetic care performed during dialysis sessions could contribute to the overall improvement of the quality of life. A national survey (Saghatchian et al., 2018) on the impact of socio-aesthetic care in oncology confirms the positive perception of this care among cancer patients. Two studies carried out in hemodialysis (Bullen et al., 2018; Unal \& Balci Akpinar, 2016) using complementary techniques, such as acupuncture, massage, or foot reflexology, highlight an impact on sleep, fatigue and quality of life. The experience of implementing socio-aesthetic care in our hemodialysis unit also leads us to believe that they positively influence the perception of the session, and therefore perhaps the quality of life measured with a validated scale, the KDQOL (Kidney Disease Quality Of Life). Our research therefore focuses on the effectiveness of social and aesthetic care during hemodialysis sessions to improve the quality of life of the hemodialysis patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
161

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 11, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

January 17, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2024

Completed
Last Updated

February 10, 2025

Status Verified

February 1, 2025

Enrollment Period

2.4 years

First QC Date

August 3, 2021

Last Update Submit

February 7, 2025

Conditions

Keywords

Quality of liferenal dialysissocio aesthetic care

Outcome Measures

Primary Outcomes (2)

  • Scale of quality of life (KDQoL)

    Quality of life is assess by using KDQoL from 0 (worse quality of life) to 100 (better quality of life)

    Day 0

  • Scale of quality of life (KDQoL)

    Quality of life is assess by using KDQoL from 0 (worse quality of life) to 100 (better quality of life)

    At Month 1

Secondary Outcomes (2)

  • Scale of anxiety and depression (HADS)

    Day 0

  • Scale of anxiety and depression (HADS)

    At Month 1

Study Arms (2)

Experimental Arm

EXPERIMENTAL
Other: dialysis and socio-aesthetic care

Control arm

ACTIVE COMPARATOR
Other: dialysis

Interventions

dialysis and socio-aesthetic care

Experimental Arm

dialysis

Control arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older;
  • Suffering from chronic kidney failure
  • On hemodialysis for 1 month
  • Dialysed 3 times a week
  • In heavy center ;
  • fluent in French;
  • Benefiting from a social security system;

You may not qualify if:

  • Having cognitive problems hindering the comprehension of the tool.
  • Under protection of justice (guardianship or curatorship).
  • Patients allergic to the care products used
  • Patients with additional precautions related to a high risk of cross-transmission such as emerging highly resistant bacteria, scabies, clostridium difficile, pulmonary tuberculosis.
  • Patients in withdrawal from other dialysis centers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damien JOLLY

Reims, France

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Dialysis

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Chemistry Techniques, AnalyticalInvestigative TechniquesChemical Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2021

First Posted

August 11, 2021

Study Start

January 17, 2022

Primary Completion

June 25, 2024

Study Completion

July 25, 2024

Last Updated

February 10, 2025

Record last verified: 2025-02

Locations